11月29日，在首届中国国际供应链促进博览会（链博会）健康生活专题论坛上，国药集团党委书记、董事长刘敬桢主题发言表示，国药集团坚定不移维护全球医药产业链供应链的公共产品属性，保障中国医药健康行业产业链供应链安全稳定，以实际行动深化医药健康产业链供应链国际合作，为构筑安全稳定、畅通高效、开放包容、互利共赢的全球医药健康产业链供应链体系提供国药方案。
首(shou)届(jie)链博会上，国(guo)药集(ji)团以(yi)“全产(chan)业(ye)(ye)链、全生(sheng)命周(zhou)期”为特(te)色整体参展(zhan)(zhan)。纵向展(zhan)(zhan)示集(ji)团各(ge)(ge)板块各(ge)(ge)链条各(ge)(ge)环节(jie)的先进技术产(chan)品和(he)未来发(fa)展(zhan)(zhan)趋势，横向展(zhan)(zhan)示现代中药链、生(sheng)物(wu)制(zhi)药链、化学制(zhi)药链、生(sheng)命健康产(chan)业(ye)(ye)链、医疗(liao)器(qi)械(xie)链、商贸流通链、医疗(liao)服(fu)务链等细分(fen)领域产(chan)品和(he)服(fu)务，助力上中下游产(chan)业(ye)(ye)合作、共同发(fa)展(zhan)(zhan)。
国药(yao)(yao)(yao)(yao)集(ji)团(tuan)将链(lian)(lian)(lian)(lian)(lian)(lian)(lian)博(bo)会平台(tai)作(zuo)(zuo)为首(shou)发(fa)阵地(di)、创新阵地(di)、合(he)作(zuo)(zuo)阵地(di)，展(zhan)示(shi)了(le)(le)一系列新产(chan)(chan)(chan)品新技(ji)术(shu)新服(fu)(fu)务(wu)。现代(dai)中(zhong)(zhong)药(yao)(yao)(yao)(yao)链(lian)(lian)(lian)(lian)(lian)(lian)(lian)全(quan)景(jing)展(zhan)示(shi)上(shang)游(you)(you)中(zhong)(zhong)药(yao)(yao)(yao)(yao)材资源、中(zhong)(zhong)游(you)(you)现代(dai)中(zhong)(zhong)药(yao)(yao)(yao)(yao)工(gong)(gong)(gong)业(ye)(ye)(ye)、下(xia)(xia)游(you)(you)中(zhong)(zhong)医(yi)(yi)(yi)药(yao)(yao)(yao)(yao)终端(duan)服(fu)(fu)务(wu)的(de)(de)(de)贯通(tong)融合(he)，种苗繁(fan)育技(ji)术(shu)实景(jing)、中(zhong)(zhong)药(yao)(yao)(yao)(yao)材GACP基(ji)(ji)地(di)、1:80三维仿真还原工(gong)(gong)(gong)厂(chang)，使中(zhong)(zhong)医(yi)(yi)(yi)药(yao)(yao)(yao)(yao)魅力可(ke)感可(ke)触(chu)。生物制药(yao)(yao)(yao)(yao)链(lian)(lian)(lian)(lian)(lian)(lian)(lian)首(shou)次展(zhan)示(shi)数(shu)(shu)字化(hua)(hua)赋能(neng)下(xia)(xia)的(de)(de)(de)生物医(yi)(yi)(yi)药(yao)(yao)(yao)(yao)产(chan)(chan)(chan)业(ye)(ye)(ye)“数(shu)(shu)字+”场景(jing)，首(shou)次展(zhan)示(shi)生物医(yi)(yi)(yi)药(yao)(yao)(yao)(yao)研(yan)发(fa)领域超算(suan)与(yu)数(shu)(shu)据中(zhong)(zhong)心应(ying)用场景(jing)，展(zhan)示(shi)疫(yi)苗生产(chan)(chan)(chan)过程(cheng)中(zhong)(zhong)细胞培(pei)养、病毒培(pei)养、超滤纯化(hua)(hua)等(deng)(deng)关键(jian)工(gong)(gong)(gong)序(xu)的(de)(de)(de)智能(neng)制造(zao)设备，以及冷链(lian)(lian)(lian)(lian)(lian)(lian)(lian)储运的(de)(de)(de)全(quan)过程(cheng)可(ke)追溯，展(zhan)现了(le)(le)国药(yao)(yao)(yao)(yao)集(ji)团(tuan)在生物医(yi)(yi)(yi)药(yao)(yao)(yao)(yao)行(xing)业(ye)(ye)(ye)上(shang)下(xia)(xia)游(you)(you)融通(tong)、产(chan)(chan)(chan)学(xue)(xue)研(yan)协同(tong)、智能(neng)化(hua)(hua)生产(chan)(chan)(chan)、全(quan)产(chan)(chan)(chan)业(ye)(ye)(ye)链(lian)(lian)(lian)(lian)(lian)(lian)(lian)打造(zao)等(deng)(deng)方面的(de)(de)(de)实践(jian)成(cheng)果。化(hua)(hua)学(xue)(xue)制药(yao)(yao)(yao)(yao)链(lian)(lian)(lian)(lian)(lian)(lian)(lian)展(zhan)示(shi)了(le)(le)从中(zhong)(zhong)间体、原料药(yao)(yao)(yao)(yao)至化(hua)(hua)学(xue)(xue)制剂的(de)(de)(de)全(quan)产(chan)(chan)(chan)业(ye)(ye)(ye)链(lian)(lian)(lian)(lian)(lian)(lian)(lian)工(gong)(gong)(gong)业(ye)(ye)(ye)实力。生命健(jian)康链(lian)(lian)(lian)(lian)(lian)(lian)(lian)展(zhan)现了(le)(le)从大健(jian)康产(chan)(chan)(chan)品到医(yi)(yi)(yi)养康养的(de)(de)(de)全(quan)产(chan)(chan)(chan)业(ye)(ye)(ye)链(lian)(lian)(lian)(lian)(lian)(lian)(lian)全(quan)生命周期服(fu)(fu)务(wu)。医(yi)(yi)(yi)疗(liao)(liao)(liao)器械链(lian)(lian)(lian)(lian)(lian)(lian)(lian)将与(yu)GE医(yi)(yi)(yi)疗(liao)(liao)(liao)共建(jian)融合(he)展(zhan)台(tai)，首(shou)发(fa)“国药(yao)(yao)(yao)(yao)影像(xiang)”工(gong)(gong)(gong)业(ye)(ye)(ye)品牌，“国药(yao)(yao)(yao)(yao)影像(xiang)”是中(zhong)(zhong)美合(he)作(zuo)(zuo)建(jian)设的(de)(de)(de)高端(duan)智能(neng)化(hua)(hua)医(yi)(yi)(yi)疗(liao)(liao)(liao)设备工(gong)(gong)(gong)业(ye)(ye)(ye)平台(tai)，以生产(chan)(chan)(chan)链(lian)(lian)(lian)(lian)(lian)(lian)(lian)、供(gong)应(ying)链(lian)(lian)(lian)(lian)(lian)(lian)(lian)为主(zhu)线(xian)，体现了(le)(le)中(zhong)(zhong)国医(yi)(yi)(yi)药(yao)(yao)(yao)(yao)行(xing)业(ye)(ye)(ye)与(yu)全(quan)球供(gong)应(ying)商携手并进的(de)(de)(de)成(cheng)功。医(yi)(yi)(yi)疗(liao)(liao)(liao)卫生链(lian)(lian)(lian)(lian)(lian)(lian)(lian)展(zhan)现国药(yao)(yao)(yao)(yao)旗下(xia)(xia)140余(yu)家(jia)各(ge)类型医(yi)(yi)(yi)疗(liao)(liao)(liao)机构(gou)布局全(quan)国的(de)(de)(de)“央企(qi)办(ban)医(yi)(yi)(yi)”服(fu)(fu)务(wu)模式。药(yao)(yao)(yao)(yao)械流通(tong)链(lian)(lian)(lian)(lian)(lian)(lian)(lian)展(zhan)示(shi)亚洲网络覆盖最(zui)广(guang)、规模最(zui)大、智能(neng)化(hua)(hua)程(cheng)度最(zui)高的(de)(de)(de)医(yi)(yi)(yi)药(yao)(yao)(yao)(yao)物流供(gong)应(ying)链(lian)(lian)(lian)(lian)(lian)(lian)(lian)，7大枢纽中(zhong)(zhong)心、30个省(sheng)级中(zhong)(zhong)心等(deng)(deng)基(ji)(ji)础(chu)设施，为北上(shang)广(guang)等(deng)(deng)全(quan)中(zhong)(zhong)国约70万家(jia)医(yi)(yi)(yi)院、药(yao)(yao)(yao)(yao)店、基(ji)(ji)层医(yi)(yi)(yi)疗(liao)(liao)(liao)机构(gou)提供(gong)医(yi)(yi)(yi)疗(liao)(liao)(liao)供(gong)应(ying)链(lian)(lian)(lian)(lian)(lian)(lian)(lian)服(fu)(fu)务(wu)，构(gou)筑了(le)(le)确保群众(zhong)用药(yao)(yao)(yao)(yao)安全(quan)稳(wen)定可(ke)及的(de)(de)(de)“国家(jia)药(yao)(yao)(yao)(yao)网”。
据(ju)悉，国(guo)药集团作为(wei)国(guo)内综合实(shi)力最强的(de)医(yi)药健康(kang)企(qi)(qi)业(ye)(ye)(ye)，世(shi)界500强最高(gao)排名(ming)第80位，1600家(jia)成员企(qi)(qi)业(ye)(ye)(ye)涵盖医(yi)药大(da)健康(kang)全产业(ye)(ye)(ye)链，拥(yong)(yong)有(you)10家(jia)上市公(gong)司和一大(da)批“专精特新”“隐形冠军(jun)”企(qi)(qi)业(ye)(ye)(ye)和“链主(zhu)”和“链属(shu)”企(qi)(qi)业(ye)(ye)(ye)。国(guo)药集团积极(ji)推动产业(ye)(ye)(ye)结构全球布局，与世(shi)界195个国(guo)家(jia)、地(di)区(qu)和国(guo)际(ji)组织建立贸易关系(xi)，拥(yong)(yong)有(you)40余项美国(guo)、欧盟、日本等(deng)国(guo)际(ji)认(ren)证和世(shi)界卫生(sheng)组织预(yu)认(ren)证，以(yi)及400多个有(you)效(xiao)的(de)海(hai)外注册证，产品服务惠及119个国(guo)家(jia)、地(di)区(qu)及国(guo)际(ji)组织，是全球医(yi)药行业(ye)(ye)(ye)产业(ye)(ye)(ye)链供(gong)应链融合发展的(de)建设(she)者(zhe)、维(wei)护者(zhe)。
刘敬桢在发言中(zhong)表(biao)示，国(guo)药集团将持续推(tui)(tui)动(dong)产(chan)(chan)业链供(gong)应链优化升级，稳固国(guo)内大(da)(da)循环主体地位(wei)、增强在国(guo)际(ji)大(da)(da)循环中(zhong)的带动(dong)能(neng)力，上中(zhong)下游衔接(jie)、大(da)(da)中(zhong)小企业融通、产(chan)(chan)学研用协同(tong)，携手医药健康行业中(zhong)外企业共(gong)同(tong)推(tui)(tui)动(dong)产(chan)(chan)业链供(gong)应链创新(xin)链资金链深度(du)融合，共(gong)同(tong)助力构建人类(lei)卫生健康共(gong)同(tong)体。
责编：朱虹宇
